StockData
Journey Medical Corp logo

Journey Medical Corp (DERM) stock

DERMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3033% below fair value
$3.90+0.20 (+5.41%)

Close on Nov 17, 2026Market cap $110.08MP/E –Yield –

Journey Medical operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Journey Medical's operating cash flow for the twelve months ending Jun 30, 2026 was -$7.49M. For fiscal 2025 it was -$12.44M. The highest annual figure on record is $5.24M in fiscal 2023.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$12.44M–
FY2024Dec 31, 2024-$9.13M-274.2%
FY2023Dec 31, 2023$5.24M–
FY2022Dec 31, 2022-$13.53M–
FY2021Dec 31, 2021-$2.18M-142.5%
FY2020Dec 31, 2020$5.13M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.73M–
Q1 FY2026Mar 31, 2026$2.91M–
Q4 FY2025Dec 31, 2025-$6.28M-382.4%
Q3 FY2025Sep 30, 2025-$2.38M–
Q2 FY2025Jun 30, 2025-$942.00K–
Q1 FY2025Mar 31, 2025-$2.83M–
Q4 FY2024Dec 31, 2024$2.23M–
Q3 FY2024Sep 30, 2024-$1.16M-106.2%
Q2 FY2024Jun 30, 2024-$5.18M–
Q1 FY2024Mar 31, 2024-$5.02M–
Q4 FY2023Dec 31, 2023-$16.52M–
Q3 FY2023Sep 30, 2023$18.75M+2020.7%
Q4 FY2022Dec 31, 2022-$3.84M–
Q3 FY2022Sep 30, 2022-$7.28M-202.5%
Q2 FY2022Jun 30, 2022-$3.30M–
Q1 FY2022Mar 31, 2022$884.00K-35.0%
Q4 FY2021Dec 31, 2021-$3.21M-163.4%
Q3 FY2021Sep 30, 2021$7.10M–
Q2 FY2021Jun 30, 2021-$7.44M–
Q1 FY2021Mar 31, 2021$1.36M–
Q4 FY2020Dec 31, 2020$5.05M–

More Journey Medical figures

See a number that looks wrong?